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ABSTRACT
We have recently shown that neither the base nor
the sugar moieties of a nucleotide is an essential
feature for its incorporation by DNA polymerases
(pols) l and b. Here we present the identification
of novel non-nucleoside triphosphate (NNTP) deri-
vatives belonging to three classes: (i) non-
substrate-specific inhibitors of DNA pol l; (ii)
substrate inhibitors which could preferentially be
incorporated by either DNA pol l wild type or its
Y505A mutant and (iii) the substrate inhibitor N-
(Biphenylcarbonyl)-4-oxobutyl triphosphate which
could be incorporated exclusively by DNA pol b in
aM g
2+-dependent manner, and preferentially pairs
with A on the template. This compound represents
the first example of a substrate lacking both nucleo-
base and ribose residue, showing distinct base-
pairing properties with normal bases. Therefore, this
NNTP analog can be considered as the prototype of
an entirely novel class of DNA pol substrates.
INTRODUCTION
DNA polymerase (pol) l is a member of the pol family X,
together with DNA pol b, DNA pol m and TDT (1). DNA
pol l is endowed with both template-dependent and template-
independent (i.e. terminal transferase) DNA polymerase
activities, as well as dRPlyase activity, suggesting multiple
cellular roles for the enzyme (2,3). Indeed, the gene encoding
DNA pol l was shown to be expressed at high level in the
developing mouse testis (2) indicating a possible function
of DNA pol l in DNA synthesis associated with meiosis.
Additional results suggest that DNA pol l may be involved
in a PCNA-dependent DNA translesion synthesis pathway
and in the repair of DSBs (4–8). DNA pol l shares 33%
sequence identity with DNA pol b (3,9,10). However, the
template-dependent polymerase activity of DNA pol l has
some distinct features compared with the one of DNA pol
b. In particular, DNA pol l appears to have evolved towards
having a preference for Mn
2+ as the metal activator (11).
DNA pols in families A, B, X and RT have binding pockets
that tightly accommodate a correct Watson–Crick base pair,
supportingthenotionthatnucleotideselectivityfortheseenzy-
mes largely depends on geometric selection for the shape and
size of correct base pairs (12,13). A correct complementarity
is required to stabilize the catalytically competent closed con-
formation (14–16). However, kinetic studies have suggested
that there is no rate-limiting step preceding catalysis for
DNA pol b (17), whereas crystallographic studies have
shown that the related enzyme DNA pol l appears to be in
a ‘closed’ conformation even in the absence of a bound
dNTP (10). Understanding the mechanisms underlying the
base selectivity of DNA pols b and l will have important
implications also in light of their ability to overcome lesions
on the template strand such as AP sites and cisplatin adducts.
Moreover, a number of evidences suggest that DNA pols l
and b show altered expression in tumors (18). Abnormal lev-
els of these enzymes might, in turn, lead to genetic instability
accelerating the cell progression towards a more severe
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doi:10.1093/nar/gkl1016tumoral phenotype. Thus, identifying the substrate recogni-
tion properties and the selectivity of these DNA pols might
lead to the development of speciﬁc inhibitors which, in
turn, can be developed into novel antitumoral drugs.
Nucleoside analogs have since long been investigated as
DNA pols inhibitors, particularly for viral and bacterial
enzymes (19). They can be broadly divided in two classes:
(i) acyclic compounds having a natural base or a base analog
but lacking a sugar and (ii) analogs bearing either non-
standard bases or modiﬁed sugars or both. The classical
example of the ﬁrst class is the antiviral compound acyclovir,
which has been designed to target herpes virus DNA pol, but
can also act as a substrate for cellular enzymes (20). Exam-
ples of the second class are nucleosides bearing methylated
bases, non-polar nucleobase isosteres and modiﬁed sugars.
All these analogs have been shown to be recognized by
viral, bacterial or cellular DNA pols as substrates (21). How-
ever, even though modiﬁed, all of them possess either a base
or a sugar or both and thus can be classiﬁed as nucleoside
analogs.
As a consequence of the urgent need of novel antivirals,
particularly against human immunodeﬁciency virus infec-
tions, novel non-nucleoside inhibitors of DNA pols emerged
recently. They have very different chemical structures, but all
share two main properties: they do not carry a triphosphate
moiety and they are not substrates for the target enzymes,
i.e. they are not incorporated into a nascent nucleic acid
chain (22,23).
We aimed to develop non-nucleoside molecules which, on
the other hand, could be incorporated by DNA pols. We
started from a very simple skeleton, namely an ethyl- or
butyl-chain, carrying on one end a triphosphate moiety and
on the other end bulky hydrophobic groups sterically similar
to nucleosides but lacking the chemical functional groups
of nucleobases. Our studies identiﬁed non-nucleoside triphos-
phate analogues (NNTPs) carrying the benzoyl-oxy-butyl
moiety (Figure 1), as selective substrates for DNA pol b
and l (24). That was the ﬁrst demonstration that neither the
base nor the sugar moieties of a nucleotide is an essential
feature for its incorporation by DNA pols l and b. However,
the incorporation of NNTPs by DNA pol l was restricted
either to DNA strands lacking a templating base, as in the
case of abasic (AP) sites, or to the mutant enzyme Y505A,
with a larger nucleotide binding pocket. On the other hand,
incorporation of NNTPs by DNA pol b was strictly dependent
on Mn
2+ as the metal activator. Thus, starting from these
results, we synthesized novel derivatives, with the aim of
(i) improving selectivity of the NNTPs towards either DNA
pol l or DNA pol b and (ii) further exploring the molecular
determinants linking the incorporation efﬁciency to the DNA
template and the enzyme active site structure. In this study,
we used three different classes of NNTPs, whose structure
is shown in Figure 1: compounds of the series I have a butyl-
triphosphate chain carrying nucleobase-like moieties, but
lacking a sugar. Compounds of the series II are close analogs
of our lead benzoyl-oxy-butyl triphosphate. Compounds of
the series III represent 2,4-dinitrophenyl amino-butyl and
-ethyl derivatives carrying various substituents. The aim of
the study was to understand how their different chemical
structures might modulate their properties as DNA pols
substrates.
MATERIALS AND METHODS
Chemicals
[g-
32P]ATP (3000 Ci/mmol) and [
3H]dTTP (40 Ci/mmol)
were from GE Healthcare Biosciences, and unlabeled dNTPs,
poly(dA)200 and oligo(dT)16 were from Roche Molecular
Biochemicals. All other reagents were of analytical grade
and were purchased from Merck or Fluka.
Chemistry
(9-Adenylmethylcarbonyl)-4-aminobutyl triphosphate (Ia)
was obtained by phosphorylation of (9-adenylmethylcarbonyl)-
4-aminobutanol (25,26). Yield 24%.
1H NMR (D2O): 8.20
and 8.10 (2H, 2s, H2 and H8), 4.99 (2H, s, CH2Ade), 3.95
(2H, m, CH2O), 3.25 (2H, m, CH2N), 1.65–1.55 (4H, m,
(CH2)2).
31PN M R( D 2O):  5.79 (1P, d, J 17.2, Pg),
 10.05 (1P, d, J 19.1, Pa),  21.68 (1P, dd, Pb). UV (H2O,
pH 6): lmax 259 nm (e ¼ 15 000). Mass (m/e): 503.0
(M
+   1).
Figure 1. Structures of the analogues used in this study. The structure of the
compound 4-O-benzoyl-oxy-butyl triphosphate is shown on top for
comparison purposes. The structures of the derivatives Ia, b, IIa, b and
IIIa–f used in this study are also shown.
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earlier described procedure (27–29).
2-Thiomethyl-6-phenyl-4-(40-hydroxybutyl)-1,2,4,-triazole
(5,1-C)(1,2,4)triazine-7-one triphosphate (Ib) was obtained
according to earlier described procedure (27) starting from
2-thiomethyl-6-phenyl-4-(40-hydroxybutyl)-1,2,4,-triazole(5,1-H)
(1,2,4) triazine-7-one. UV (H2O, pH 6): lmax 250 nm
(e 26000). Yield 23%.
1HN M R( D 2O): 7.89, 7.51 (5H,
2m, Ph), 4.42 (2H, m, CH2O), 3.99 (2H, m, CH2N), 2.68
(3H, s, SCH3), 2.04, 1.74 (4H, 2m, –(CH2)2–).
31P NMR
(D2O):  9.28 (1P, m, Pg),  10.26 (1P, m, Pa),  22.10
(1P, m, Pb).
N-(Benzyloxycarbonyl)-4-aminobutyl triphosphate (IIa)
was obtained by phosphorylation of N-(benzyloxycarbonyl)-
4-aminobutanol according to (27). Yield 37 mg (29%).
1H
NMR (D2O): 7.40 (5H, m, C6H5), 5.08 (2H, s, CH2 (Cbz)),
3.95 (2H, m, CH2O), 3.14 (2H, m, CH2N), 1.65–61.53
(4H, m, (CH2)2).
31PN M R( D 2O):  10.22 (1P, d, J 19.2,
Pg),  10.35 (1P, d, J 20.3, Pa),  22.68 (1P, dd, Pb). UV
(H2O, pH 6): lmax 257 nm. Mass (m/e): 461.0 (M
+   1).
(Biphenylcarbonyl)-4-oxobutyl triphosphate (IIb) was
obtained by phosphorylation of 4-biphenylcarboxybutanol
according to (27). Yield 31%. UV (H2O, pH 7.0): lmax
273 nm (e 24000).
1H NMR (D2O): d 7.73 (d, 2H, J 8.42 Hz,
Ar), 7.65 (t, 4H, J 9.01 Hz, Ar), 7.45 (t, 2H, J 7.46 Hz, H-8),
7.31 (d, 1H, Ar), 3.95 (m, 2H, CH2O), 3.45 (m, 2H, CH2N),
1.66 (m, 4H, (CH2)2-central).
31PN M R( D 2O): d  8.74 (d,
1P, J 19.5 Hz, Pg),  10.36 (d, 1P, J 20.3 Hz, Pa),  21.9
(dd, 1P, Pb).
The synthesis ofcompounds IIIa–fwas asdescribedin(30).
N-(2,4-Dinitrophenyl)-4-aminobutyl triphosphate (IIIa).
Yield 30%. UV-VIS(H2O, pH 6): lmax 265 nm (e 8300),
363 nm (e 17500).
1HN M R( D 2O): 9.19 (1H, d, J 2.8,
H3), 8.30 (3H, dd, H-5), 7.19 (1H, d, J 9.65, H6), 3.99
(2H, m, CH2O), 3.54 (2H, t, J 6.8, CH2N), 1.82–1.72 (4H,
m, (CH2)2).
31PN M R( D 2):  10.10 (1P, d, J 19.3, Pg),
 10.31 (1P, d, J 20.3, Pa),  22.64 (1P, dd, Pb).
N-[6-N-(2,4-Dinitrophenyl)aminohexanoyl]-2-aminoethyl
triphosphate (IIIb). Yield 28%. UV-VIS (H2O, pH 7.0): lmax
363 nm (e 17500), 265 nm (e 8340).
1HN M R( D 2O): d 1.28
(m, 2H, CH2-central), 1.46 (q, 2H, J ¼ 6.48 Hz, CH2), 1.55
(q, 2H, J ¼ 6.48 Hz, CH2), 2.13 (t, 2H, J ¼ 7.47 Hz,
CH2CO), 3.27 (t, 1H, J ¼ 4.98 Hz, CH2NH), 3.34 (t, 1H,
J ¼ 7.16 Hz, CH2NH), 3.88 (m, 2H, CH2OP), 6.97 (d, 1H,
J ¼ 9.65 Hz, H-6 (DNP)), 8.10 (dd, 1H, J ¼ 2.8 Hz, H-5
(DNP)), 8.93 (d, 1H, H-3 (DNP)).
31P NMR (D2O):
d  7.88 (d, 1P, J ¼ 21.4 Hz, Pg),  10.32 (d, 1P, J ¼ 19.3
Hz, Pa),  21.77 (dd, 1P, Pb).
N-(2,4-Dinitro-5-ﬂuorophenyl)-4-aminobutyl triphosphate
(IIIc). Yield 15%. UV (H2O, pH 6): lmax 265 nm (e 9100),
349 nm (e 16000).
1HN M R( D 2O): 9.10 (1H, d, J 8.1,
H3), 6.94 (1H, d, J 15.6, H6), 4.01 (2H, m, CH2O), 3.50
(2H, t, J 6.8, CH2N), 1.77 (4H, m, (CH2)2).
31P NMR
(D2O):  10.12 (1P, d, J 19.3, Pg),  10.32 (1P, d, J 20.3,
Pa),  22.65 (1P, dd, Pb).
N-(2,4-Dinitro-5-ﬂuorophenyl)-2-aminoethyl triphosphate
(IIId). Yield 21%. UV (H2O, pH 6): lmax 265 nm (e 9000),
349 nm (e 15900).
1HN M R( D 2O): 9.10 (1H, d, J 8.1, H3),
7.04 (1H, d, J 14.6, H6), 4.22 (2H, dt, CH2O), 3.75 (2H, t,
J 5.3, CH2N).
31PN M R( D 2O):  5.72 (1P, d, J 20.3, Pg),
 10.39 (1P, d, J 19.3, Pa),  21.50 (1P, dd, Pb).
N-(2,4-dinitro-5-imidazolylphenyl)-4-aminobutyl triphos-
phate (IIIe). Yield 23%. UV (H2O, pH 6): lmax 272 nm
(e 5800), 365 nm (e 7000).
1H NMR (D2O): 9.19 (1H,
s, H3), 8.30, 7.45 and 7.33 (3H, 3 br s, Im), 7.19 (1H, s,
H6), 3.99 (2H, m, CH2O), 3.54 (2H, t, J 6.8, CH2N), 1.82–
1.72 (4H, m, (CH2)2).
31PN M R( D 2O):  10.10 (1P, d,
J 19.3, Pg),  10.31 (1P, d, J 20.3, Pa),  22.64 (1P, dd, Pb).
N-(2,4-Dinitro-5-imidazolylphenyl)-2-aminoethyl triphos-
phate (IIIf). Yield 17%. UV (H2O, pH 6): lmax 272 nm
(e 5800), 365 nm (e 7000)
1HN M R( D 2O): 9.24 (1H, s,
H3), 8.96, 7.67 and 7.55 (3H, 3 br s, Im), 7.50 (1H, s, H6),
4.40 (2H, m, CH2O), 3.83 (2H, t, J 5.3, CH2N).
31P NMR
(D2O):  10.24 (1P, d, J 19.3, Pg),  10.83 (1P, d, J
20.3, Pa),  22.61 (1P, dd, Pb).
The presence of ﬂuoro atoms in the compounds IIIc and
IIId were conﬁrmed by the
1H NMR spectra. The ﬂuoro
atom at 5 position (IIIc and IIId), interacts with H6 and
H3 atoms, and, as a result, the coupling constants increased
compared to those in the case of H at 5 position (IIIa):
IIIc
1H NMR (D2O): 9.10 (1H, d, J 8.1, H3) and 6.94 (1H,
d, J 15.6, H6); IIId  9.10 (1H, d, J 8.1, H3), 7.04 (1H, d,
J 14.6, H6); IIIa 9.19 (1H, d, J 2.8, H3), 8.30 (3H, dd,
H-5), 7.19 (1H, d, J 9.65, H6); when imidazolyl was located
at 5 position (IIIe), then the signals from H6 and H3 appeared
as singlets: 9.19 (1H, s, H3), 7.19 (1H, s, H6).
Nucleic acids substrates. All oligonucleotides were puriﬁed
from polyacrylamide denaturing gels. The sequences are as
follows:
18/75merAP/Control: 50-GATCGGGAGGGTAGGAA-
TATTGAG[X/G]ATGAAGGGTTGAGTTGAG-
TGGAGATAGTGGAGGGTAGTATGGTGGATA-30;
18/40merA: 30-ATAGGTGGTTATGATGGGATGCTAT-
GATAGAGGTGAGTTG-50;
19/40merT: 30-ATAGGTGGTTATGATGGGATGCTAT-
GATAGAGGTGAGTTG-50;
20/40merG: 30-ATAGGTGGTTATGATGGGATGCTAT-
GATAGAGGTGAGTTG-50;
21/40merC: 30-ATAGGTGGTTATGATGGGATGCTAT-
GATAGAGGTGAGTTG-50;
19mer: 50-CCGTCAATTCCTGTAGTCT-30.
The sequence underlined corresponds to the primer hybri-
dization position. X indicates the position of the AP site,
which corresponds to a G in the control template. The
19mer was used as a primer for TDT. The different primers
were 50-labelled with T4 polynucleotide kinase (New
England Biolabs) in the presence of [g-
32P]ATP. For the
preparation of the corresponding primer/template substrates,
each labelled primer was mixed to the complementary
template oligonucleotide at 1:1 (M/M) ratio in the presence
of 25 mM Tris–HCl (pH 8.0) and 50 mM KCl, heated at
80 C for 3 min and then slowly cooled down at room
temperature.
Proteins production and purification
Recombinant his-tagged human wild-type and Y505A mutant
pol l were expressed and puriﬁed as described previously
(4,31). After puriﬁcation, the proteins were >90% homo-
genous, as judged by SDS–PAGE and Coomassie staining.
Human pol b and calf thymus TDT were from Trevigen.
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DNA polymerase assay. Human pol l and pol b activities on
poly(dA)/oligo(dT)10:1 was assayed in a ﬁnal volume of 25 ml
containing 50 mM Tris–HCl (pH 7.0), 0.25 mg/ml BSA,
1 mM DTT, 0.5 mM MnCl2,  0.2 mM poly(dA)/oligo(dT)10:1
(30-OH ends), 50 nM pol and 5 mM[
3H]dTTP (5 Ci/mmol),
unless otherwise indicated in the ﬁgure legends. All reactions
were incubated at 37 C for 15 min unless otherwise stated
and the DNA precipitated with 10% trichloroacetic acid.
Insoluble radioactive material was determined by scintillation
counting as described in (4).
Terminal deoxyribonucleotidyl transferase assay. Pol l
template-independent (i.e. terminal transferase) activity was
assayed in a ﬁnal volume of 25 ml containing 50 mM
Tris–HCl (pH 7.0), 0.25 mg/ml BSA, 1 mM DTT, 0.5 mM
MnCl2, 0.2 mM ss 30mer DNA oligonucleotide, unless other-
wise stated. Enzymes and [
3H]dNTPs (10 Ci/mmol), were
added as indicated in the ﬁgure legends. All reactions were
incubated at 37 C for 10 min, unless otherwise indicated in
the ﬁgures and the DNA was precipitated with 10% trichlor-
oacetic acid. Insoluble radioactive material was determined
by scintillation counting as described in (4).
For denaturing gel analysis of DNA pol l synthesis
products, the reaction mixtures contained 50 mM Tris–HCl
(pH 7.0), 0.25 mg/ml BSA, 1 mM DTT and 30 nM
(0.3 pmols of 30-OH ends) of the different 50-
32P-labelled
primer/templates (unless otherwise stated) and 30 nM
enzyme. Concentrations of NNTPs, dNTPs and either Mg
2+
or Mn
2+ were as indicated in the corresponding ﬁgure leg-
ends. Reactions were incubated at 37 C for 10 min and
then stopped by the addition of standard denaturing gel load-
ing buffer (95% formamide, xylene cyanol and bromophenol
blue), heated at 95 C for 3 min and loaded on a 7 M urea/
15% polyacrylamide gel. For the elongation reaction by
calf thymus TDT, the reaction mixture (10 ml) contained
50 mM cacodylate buffer (pH 7.2), 100 nM 50-
32P-labelled
19mer primer, 1 mM DTT, 2 mM Co
2+, 0.25 U of TDT
and the tested compounds as shown in the ﬁgure legends.
After incubation at 37 C for 10 min, the reactions were
quenched by the addition of standard denaturing gel loading
buffer as described above and the reaction mixtures were
loaded onto a 20% denaturing PAGE and subjected to elec-
trophoresis for  3 h at 2000 V followed by the gel exposure
with a Kodak ﬁlm.
Inhibition assays
Reactions were performed under the conditions described for
the corresponding enzymatic assay. Incorporation of radioac-
tive dTTP into poly(dA)/oligo(dT) at different concentrations
of DNA or dNTP was monitored in the presence of increasing
amounts of inhibitor as indicated in the ﬁgure legends. Dose–
response curves were generated by computer ﬁtting of the
data to the the following equation:
Eð%Þ ¼
Emax
ð1 þ I
ID50 Þ
1
where E(%) is the fraction of enzyme’s activity measured in
the presence of the inhibitor, Emax is the activity in the
absence of the inhibitor, I is the inhibitor concentration and
ID50 is the inhibitor concentration at which E(%) ¼ 0.5 Emax.
For inhibition constant (Ki) determination, the variation of
the ID50 values as a function of the nucleotide substrate con-
centration was analysed according to a fully competitive
mechanism:
ID50 ¼ Ki  

1 þ
S
Km

: 2
Steady-state kinetic analysis
Reactions were performed in the presence of 50 mM Tris–
HCl (pH 7.0), 0.25 mg/ml BSA, 1 mM DTT, 50 nM
(0.5 pmols of 30OH ends) of the different 50-
32P-labelled
primer/templates, 30 nM pol l and either Mn
2+ or Mg
2+ as
indicated. Reactions were incubated for 10 min, which was
the midpoint of the linear range of the reaction, as determined
in preliminary experiments. Under all conditions, the amount
of elongated primers was always <20–25% of the input.
Maximum nucleotide substrate utilization was <10% of the
input. Quantiﬁcation was performed by scanning densitome-
try. The initial velocities of the reaction were calculated from
the values of integrated gel band intensities:
I
 
T
IT 1
‚
where T is the target site, the template position of interest;
I
 
Tis the sum of the integrated intensities at positions T,
T + 1 ...T + n.
All the intensities values were normalized to the total
intensity of the corresponding lane to correct for differences
in gel loading. An empty lane was scanned and the corre-
sponding value subtracted as background. The apparent Kd
and kcat values were calculated by plotting the initial veloci-
ties in dependence of the substrate concentrations and ﬁtting
the data according to the Michaelis–Menten equation in the
form:
v ¼
Vmax
1 þ Km
½S 
 3
kcat values were calculated from the relationship:
Vmax ¼ kcat½E 0
where [E]0 is the input enzyme concentration.
Since we assumed that [E]0 ¼ [ES] at steady-state, kcat
values are upper estimates of the true constants, and thus
are referred as apparent kcat [kcat(app)]. Thus, kcat/Km are
also relative values, i.e. upper estimates of the true speciﬁcity
constant.
Nucleotide incorporation efﬁciencies were deﬁned as the
kcat/Km ratio. Under single nucleotide incorporation condi-
tions kcat ¼ kpolkoff/(kpol + koff) and Km ¼ Kskoff/(kpol +
koff), where kpol is the true polymerization rate, koff is the dis-
sociation rate of the enzyme–primer complex and Ks is the
true Michelis constant for nucleotide binding. Thus, kcat/Km
values equal to kpol/Ks. Frequency of IIb incorporation (f)
was calculated as (kcat/Km)IIb/(kcat/Km)dNTP. Selectivity was
expressed as 1/f.
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Inhibition of DNA polymerases b and l by NNTPs
DNA pols b and l were challenged with the different NNTPs
shown in Figure 1. As summarized in Table 1, several of the
tested compounds (Ia, Ib, IIa, IIb, IIIa, IIIc) were able to
inhibit pol l wild type in the low micromolar range. On the
contrary, DNA pol b was not inhibited by these compounds,
with the exception of compound IIb and, to a much lower
extent, compounds Ib and IIa. In all cases, the inhibition
was non-competitive with respect to the DNA substrate and
purely competitive with the nucleotide substrate (data not
shown). Next, the same set of compounds was tested against
the DNA pol l mutant Y505A. As summarized in Table 1,
all the tested NNTPs were able to inhibit the mutant enzyme.
In particular, compounds IIIb, IIId, IIIe and IIIf, which
were inactive against the wild type, showed signiﬁcant inhi-
bitory potencies towards the Y505A mutant. None of these
NNTPs showed detectable inhibition against other DNA
pols, such as Escherichia coli DNA pol I, HIV-1 RT and
human DNA pol a, indicating speciﬁcity of these compounds
for the family X DNA pols l and b (data not shown). Also,
the corresponding unphosphorylated derivatives were tested
and none of them proved to be able to inhibit any of the
DNA pols used (data not shown).
DNA polymerase l and its mutant Y505A show different
abilities of incorporating NNTPs in the presence of an abasic
site on the template strand. The different NNTPs shown in
Figure 1 were evaluated for their ability to be incorporated
by DNA pol l wild type and the Y505A mutant on a DNA
template either undamaged or bearing an abasic (AP) site at
position +1. As shown in Figure 2A, DNA pol l wild type
on the undamaged template was able to incorporate only
compound IIb, whereas in the presence of an AP site, also
compounds Ia and IIa, together with IIb, could be incor-
porated. When the mutant Y505A was tested, some striking
differences emerged. As shown in Figure 2B, compound
IIb was now incorporated opposite to an AP site only. More-
over, compound Ib, which was not a substrate for the wild-
type enzyme, was incorporated on both templates, with a
higher efﬁciency on the intact one. Another interesting differ-
ence was that compound Ia was now incorporated on both
templates by the mutant enzyme. No incorporation could be
detected for both enzymes when Mg
2+ replaced Mn
2+.
Thus, it appears that both the presence/absence of tyrosine
505 in the nucleotide binding site, and the nature of the tem-
plate (either undamaged or carrying an AP site) differentially
affected the ability of various NNTPs to act as substrates for
DNA pol l. As apparent by the accumulation of only +1
products, all the compounds acted as chain terminators.
This was expected, due to the lack of available 30-hydroxyl
groups for subsequent elongation. In order to investigate in
more details the observed differences in NNTPs incorporation
by DNA pol l and the Y505A mutant, the kinetic parameters
(Km, kcat, kcat/Km) for the incorporation reaction were deter-
mined and the calculated values are summarized in Table 2.
As controls, kinetic parameters for the incorporation of dCTP
or dATP, depending on the template used, were also deter-
mined. Inspection of these data revealed several differences,
discussed in detail in the following sections.
Compound Ib requires the presence of a templating
base and the absence of tyrosine 505 for efficient
incorporation by DNA polymerase l
As shown in Figure 2B, compound Ib could be incorporated
on both templates but only by the Y505A mutant. However,
as summarized in Table 2, the incorporation efﬁciency
(kcat/Km) for compound Ib was 6.5-fold higher on the intact
template than opposite to an abasic site. Together, these
results suggest that tyrosine 505 prevents incorporation,
very likely through a steric gate mechanism, whereas the
presence of a templating base increases incorporation pro-
bably helping proper positioning of the analogs in the
active site.
Compound IIa requires the absence of a templating
base and the absence of tyrosine 505 for efficient
incorporation by DNA polymerase l
As shown in Table 2, compound IIa could be incorporated by
DNA pol l either wild type or the Y505A mutant, opposite to
an AP site only. Comparison of the catalytic efﬁciency of
incorporation opposite an AP site by DNA pol l and the
Y505A mutant revealed that the lack of tyrosine 505 resulted
in a higher incorporation efﬁciency (Table 2). Thus, incorp-
oration of compound IIa was affected by the presence of
both a templating base and tyrosine 505.
Table 1. Inhibition potencies of non-nucleoside triphosphate analogs towards DNA polymerases l and b
Inhibitor DNA pol l wt DNA pol l Y505A DNA pol b
Ki (mM)
a Inhibition Ki (mM) Inhibition Ki (mM) Inhibition
Ia 2.8 (±0.2) FC versus dTTP
b 3.8 (±0.3) FC versus dTTP
b >100 n.d.
c
Ib 2.7 (±0.2) FC versus dTTP
b 1.8 (±0.1) FC versus dTTP
b 68 (±6) FC versus dTTP
b
Ia 1.7 (±0.1) FC versus dTTP
b 1.6 (±0.1) FC versus dTTP
b 70 (±6) FC versus dTTP
b
Ib 1.1 (±0.1) FC versus dTTP
b 0.4 (±0.06) FC versus dTTP
b 4.8 (±0.2) FC versus dTTP
b
IIIa 1.2 (±0.1) FC versus dTTP
b 3.5 (±0.3) FC versus dTTP
b >100 n.d.
c
IIIb >100 n.d.
c 9.1 (±0.8) FC versus dTTP
b >100 n.d.
c
IIIc 3.1 (±0.3) FC versus dTTP
b 6.5 (±0.5) FC versus dTTP
b >100 n.d.
c
IIId >100 n.d.
c 14.4 (±0.8) FC versus dTTP
b >100 n.d.
c
IIIe >100 n.d.
c 15.4 (±0.7) FC versus dTTP
b >100 n.d.
c
IIIf >100 n.d.
c 0.5 (±0.07) FC versus dTTP
b >100 n.d.
c
aInhibition constants (Ki) values represent the mean of three independent experiments. Number in parantheses are ±SD. For details see Materials and Methods.
bFC, fully competitive with respect to the nucleotide (dTTP) substrate. For details see Materials and Methods.
cn.d., not determined.
Nucleic Acids Research, 2007, Vol. 35, No. 1 49Compound IIb requires the absence of a templating
base and the presence of tyrosine 505 for efficient
incorporation by DNA polymerase l
A different behaviour with respect to compounds Ia and IIa
was observed in the case of compound IIb. As shown in
Figure 3A and summarized in Table 2, the incorporation efﬁ-
ciency of compound IIb by DNA pol l wild type was 22-fold
higher opposite an abasic site than on the intact template.
Figure 2. Incorporation of non-nucleoside triphosphate analogues (NNTPs)
by DNA polymerase l wt and the Y505A mutant. Reactions were carried out
as detailed in Materials and Methods. The different migration of the +1
products (indicated by arrows) are due to different electrophoretic mobilities
of the incorporated NNTPs. The corresponding incorporation products are
indicated with arrows. The different structures resulted in different
electrophoretic mobility among the NNTPs. (A) The various NNTPs
(10 mM)were testedforincorporation oppositeto anabasic site(lanes1–10)or
on an intact template (lanes 11–20) and in the presence of Mn
2+. Lane 21,
reactionwas carriedoutin the presence of100 mM ofall fourdNTPs.(B)A si n
(A) but in the presence of the DNA pol l Y505A mutant. Lane 16, control
reaction in the absence of added nucleotides.
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50 Nucleic Acids Research, 2007, Vol. 35, No. 1For comparison, the incorporation of dCTP on both templates
by DNA pol l is shown in Figure 3B. The DNA pol l
mutant Y505A showed an efﬁciency of incorporation of
compound IIb opposite an abasic site, which was 12-fold
lower than the corresponding value measured for DNA pol
l wild type (Table 2). No incorporation of this analogue by
the Y505A mutant could be detected with the intact tem-
plate (Figure 3C). Together, these results clearly indicated
that incorporation of compound IIb was dependent both on
the presence of tyrosine 505 and on the absence of a
templating base.
The incorporation of compound IIb by DNA
polymerase b is modulated by the nature
of the activating metal
Nucleotide incorporation by DNA pols is a strictly metal-
ion-dependent mechanism (1). In the case of DNA pol l,
Figure 3. Incorporation of compound IIb by DNA polymerase l requires the presence of both an abasic site on the template strand and tyrosine 505 of DNA
polymerase l. Reactions were carried out as detailed in Materials and Methods. The sequence of the first positions on template used is shown on the left-hand
side of the panels. The position +1 was a G for the control template and an AP site for the damaged template. (A) Increasing concentrations of compound IIb
were titrated in the reaction in the presence of either the AP (lanes 1–5) or the undamaged (lanes 6–10) templates. Lane 11, all four dNTPs at 100 mM. Lane 12,
control reaction in the absence of added nucleotides. (B) Increasing concentrations of dCTP were titrated in the reaction in the presence of either the AP (lanes
1–4) or the undamaged (lanes 6–9) templates. Lane 10, control reaction in the absence of added nucleotides. (C) As in (A), but in the presence of the DNA pol l
Y505A mutant. Lane 11, all four dNTPs at 100 mM.
Nucleic Acids Research, 2007, Vol. 35, No. 1 51incorporation of the NNTPs was observed only in the pres-
ence of its optimal activator, Mn
2+. As shown in Table 1,
among the tested NNTPs, only compound IIb proved to be
able to signiﬁcantly inhibit DNA pol b activity. Thus, we
tested whether this compound could be incorporated by
DNA pol b. As shown in Figure 4A, in the presence of
Mn
2+, DNA pol b incorporated compound IIb both on an
intact template and opposite to an AP site. As shown in
Figure 4B, DNA pol b incorporated dCTP, as expected, on
the undamaged template, whereas it exclusively incorporated
dATP opposite the AP site. The incorporation efﬁciency of
compound IIb by DNA pol b was 2-fold higher in the pres-
ence of the undamaged template, with respect to the one
carrying an AP site (Table 2). This behaviour was opposite
to the one observed for DNA pol l with the same compound
(Figure 3 and Table 2). When Mn
2+ was replaced by Mg
2+,
this difference became even more striking, so that compound
IIb could be exclusively incorporated on the undamaged
Figure 4. Incorporation of compound IIb by DNA polymerase b is modulated by the activating metal. Reactions were carried out as detailed in Materials and
Methods. The sequence of the first positions on template used is shown on the left-hand side of the panels. The position +1 was a G for the control template and
an AP site for the damaged template. (A) Increasing concentrations of compound IIb were titrated in the reaction in the presence of 1 mM Mn
2+ and either the AP
(lanes 1–5) or the undamaged (lanes 6–10) templates. Lane 11, all four dNTPs at 100 mM. Lane 12, control reaction in the absence of added nucleotides.
(B) Normal dNTPs at 0.5 mM, were used as substrates for the incorporation reaction by DNA pol b either alone (dCTP, lanes 1 and 6; dATP, lanes 2 and 7; dGTP,
lanes 3 and 8; dTTP, lanes 4 and 9) or in combination (lanes 5 and 10), in the presence of the control template (lanes 1–5) or the AP template (lanes 6–10).
(C) Selectivity for incorporation of compound IIb on the different templates in the presence of Mn
2+ was calculated with respect to normal nucleotides, as
described in Material and Methods. Black bars, selectivity of DNA pol l wild type for dCTP incorporation versus IIb; light grey bar, selectivity of DNA pol l
Y505A for dCTP incorporation versus IIb; grey bar, selectivity of DNA pol b for dCTP incorporation versus IIb; black bar, selectivity of DNA pol b for dATP
incorporation versus IIb. C, control template; AP, abasic site template. (D) As in (A), but in the presence of 1 mM Mg
2+. Lane 11, all four dNTPs at 100 mM;
Lane 12, control reaction in the absence of added nucleotides.
52 Nucleic Acids Research, 2007, Vol. 35, No. 1template by DNA pol b (Figure 4D). Thus, in the presence of
Mg
2+, the incorporation of compound IIb by DNA pol b
became strictly dependent on the presence of a templating
base. Replacement of Mn
2+ with Mg
2+, however, greatly
enhanced the preference for incorporation of dCTP versus
IIb opposite a template G by DNA pol b, which increased
from 23- to 239-fold, as apparent by the comparison of the
respective kcat/Km values (Table 2).
DNA polymerases l and b show different selectivity
for incorporation of compound IIb
The selectivity indexes (deﬁned as the reciprocal of the
incorporation frequencies, 1/f, see Materials and Methods)
for incorporation of compound IIb by DNA pol l and b
were determined and their values are shown in Figure 4C.
Since the templating base at position +1 was G, and since
DNA pol l preferentially incorporates dCTP opposite an
AP site (32) (Figure 3B), selectivity was determined for
dCTP incorporation versus IIb in the case of DNA pol l,
both on the undamaged or the AP template. In the case of
DNA pol b, dCTP was used as a control for the undamaged
template, whereas selectivity for incorporation opposite an
AP site was calculated with respect to dATP, which is pref-
erentially incorporated by DNA pol b opposite this particular
lesion (32) (Figure 4B). Comparison was possible only for the
reaction in the presence of Mn
2+, due to the lack of detectable
incorporation of this analog by DNA pol l in the presence of
Mg
2+. Compound IIb proved to be a poorer substrate than
dCTP on the control template for both DNA pol l and b
(24- and 23-fold less efﬁcient, respectively). However, the
two enzymes showed a clear difference when incorporating
compound IIb opposite an AP site. In fact, whereas DNA
pol b still showed a 7.3-fold preference for dATP versus
IIb incorporation, DNA pol l wild type incorporated com-
pound IIb 2.2-fold more frequently than dCTP opposite the
lesion. The DNA pol l Y505A mutant, on the other hand,
showed a 5.3-fold preference for dCTP versus IIb incorpora-
tion opposite the lesion.
Base-pairing properties of compound IIb as a DNA
polymerase b substrate
In the presence of Mg
2+, compound IIb strictly required
the presence of a templating base for its incorporation by
DNA pol b, thus behaving like a bona ﬁde nucleotide sub-
strate, even though biphenyl residue lacks any obvious
resemblance to a nucleobase (Figure 4B). Thus, it was inter-
esting to see whether this compound showed any preferential
base-pairing capability. To this aim, compound IIb was
tested for its ability to be incorporated opposite to each of
the four possible templating bases A, T, G and C. A 40mer
oligonucleotide was hybridized to four different primers of
18 nt, 19 nt, 20 nt and 21 nt, respectively, resulting in each
case in a primer/template bearing at +1 position either A,
T, G or C as the templating base. A typical experiment is
shown in Figure 5A. Kinetic parameters Km, kcat(app), kcat/
Km for compound IIb incorporation were determined for
each templating base. Incorporation of the correct comple-
mentary nucleotide was also monitored in parallel, and the
corresponding kinetic parameters determined, allowing the
calculation of the relative incorporation frequency for each
base pair (f) deﬁned as (kcat/Km)IIb/(kcat/Km)dNTP. The calcu-
lated values are listed in Table 3. It can be clearly seen that
compound IIb showed a base-pairing hierarchy for incorpora-
tion by DNA pol b in the presence of Mg
2+, with A being the
best templating base, followed by G and T. No incorporation
could be detected when C was used as the templating base
(Table 3 and Figure 5A). Figure 5B shows a comparison of
the selectivity indexes, deﬁned as 1/f, for compound IIb incor-
poration by DNA pol b opposite A, T and G, with respect to
the complementary nucleotides dTTP, dATP and dCTP,
respectively. Selectivity was lowest opposite A (1/f ¼ 95),
whereas it increased 5-fold opposite G (1/f ¼ 476) and
15-fold opposite T (1/f ¼ 1428). Thus, compound IIb
preferentially paired with A when incorporated by DNA pol
b in the presence of Mg
2+. However, it proved to be still a
relatively poor substrate, being 95-fold less efﬁciently
incorporated than normal dTTP opposite a template A.
Family X DNA polymerases and terminal
transferases show distinct substrate specificities
with respect to NNTPs
Beside DNA pols b, l and m, family X also comprises the
TDT enzyme. DNA pol l is unique among family X mem-
bers, since it possesses a template-independent DNA synthe-
tic activity very similar to the one of TDT. Thus, it was of
interest to compare the substrate speciﬁcities of the tdt-like
activity of pol l and the TDT enzyme with respect to the
NNTPs. None of the NNTPs tested was incorporated by pol
l-tdt activity on a ssDNA template, not even those which
Figure 5. Compound IIb is preferentially incorporated by DNA polymerase b
opposite an A on the template strand. (A) Reactions were carried out as
detailed in Materials and Methods in the presence of 1 mM Mg
2+. Increasing
concentrations of compound IIb were titrated in the reaction in the presence
of the 18/40merA (lanes 1–5), 19/40merT (lanes 6–10), 20/40merG (lanes
11–15) or 21/40merC (lanes 16–20) templates, respectively. (B) The
selectivity index (1/f) for compound IIb incorporation opposite the
templating bases A, G and T was calculated as described in Material and
Methods. The calculated 1/f values are indicated on top of each bar.
Nucleic Acids Research, 2007, Vol. 35, No. 1 53could be incorporated by its template-dependent activity such
as Ib and IIb (data not shown). On the opposite, TDT could
efﬁciently incorporate all NNTPs tested albeit with different
efﬁcacy (Figure 6). By comparing the intensities of the bands
corresponding to the +1 products, the efﬁciencies of incorp-
oration for compounds IIIb and IIIe were 50- to 100-fold
lower than those of compounds IIIa, IIIc, IIId and IIIf,
whereas compound Ib was 100-fold less efﬁcient as a sub-
strate than compound Ia. These results suggest different sub-
strate afﬁnities not only among the family X members DNA
pol b, DNA pol l and TDT, but also between the template-
independent and template-dependent activities of DNA pol l.
DISCUSSION
Based on their properties, the novel NNTPs described here
can be assigned to three different classes: (i) non-substrate-
speciﬁc inhibitors of DNA pol l (Figure 1, compounds of
the series III); (ii) substrate inhibitors which could be pre-
ferentially incorporated by either DNA pol l wild type or
the Y505A mutant (Figure 1, compounds of the series I
and II) and (iii) a substrate inhibitor which could be incor-
porated by DNA pol b exclusively in a strictly template-
dependent manner and in the presence of Mg
2+ only
(Figure 1, compound IIb).
Comparison of the different inhibition potencies of the
compounds of the series III against pol l, revealed some
interesting features of this class of analogues. In the case of
the mutant Y505A, addition of a ﬂuorine substituent at the
dinitrophenyl ring of compound IIIa, to generate compound
IIIc, decreased the potency of inhibition. Shortening the lin-
ker chain from butyl- (compound IIIc) to ethyl- (compound
IIId), also resulted in lower inhibition potency. Replacement
of the ﬂuoro-substituent of compound IIIc with an imidazole
group (compound IIIf) generated the most potent inhibitor of
this class. Contrary to the ﬂuoro-substituted compounds, in
the case of the imidazolyl-derivatives shortening the linker
chain from butyl- (compound IIIe) to ethyl- (compound
IIIf), increased the inhibition potency. The same regularity
was observed when the compounds were tested as substrates
towards TDT, where the potency of IIIf, bearing an ethyl-
linker, was  100 times higher than that of IIIe bearing a
butyl-linker. Thus, both the nature of the substituents and
the length of the alkyl chain seemed to be important determi-
nants for the inhibitory activity towards TDT as well as the
DNA pol l Y505A mutant. When the activities of the same
compounds were analysed in the case of the wild-type
DNA polymerase l, a decrease in inhibitory potency could
be observed going from compound IIIa to compound IIIc,
similarly to the Y505A mutant. However, the other ﬂuoro-
or imidazolyl-substituted compounds (IIIb, IIId, IIIe and
IIIf) were inactive against the wild-type enzyme, indi-
cating that insertion of a substituent at the dinitrophenyl
ring might cause steric hindrance with the side chain of
tyrosine 505.
The compounds Ia, Ib, IIa and IIb constitute the second
class, i.e. the substrate inhibitors of DNA pol l. All of
them were sensitive to steric factors, such as the presence/
absence of a templating base and/or of the residue tyrosine
505 in the DNA pol l active site. The tyrosine 505 residue
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54 Nucleic Acids Research, 2007, Vol. 35, No. 1has been shown to modulate the ability of DNA pol l to
discriminate between purines and pyrimidines (31). The crys-
tal structure of the complex of DNA pol l with its substrates,
clearly showed that tyrosine 505 acted as a ‘gate’ to limit the
access of the incoming nucleotide to its binding pocket (10).
The presence of a natural base (Ia) or a base analog (Ib)i n
the place of a phenyl group did not improve the substrate
properties of the compounds. For example, incorporation of
compound Ib by DNA pol l wild type occurred only opposite
an AP site, but with a lower efﬁciency than either compound
IIb or dCTP (Table 2). Only the DNA pol l mutant Y505A
was able to incorporate the compound Ib on a normal tem-
plate opposite a G, with an efﬁciency close to normal
dCTP, indicating that the main determinant of selectivity
was a steric one.
Small structural modiﬁcations in the hydrophobic moiety
of the NNTPs can drastically change their substrate proper-
ties. For example, incorporation of the benzyloxycarbonyl
derivative IIa by DNA pol l was restricted by steric mecha-
nisms, requiring the absence of both the templating base and
the ‘gating’ residue tyrosine 505. However, the structurally
related biphenylcarbonyl derivative IIb, required the pres-
ence of tyrosine 505, suggesting that the pendant hydrophobic
group might take stabilizing p–p stacking interactions with
the side chain of tyrosine 505.
Whereas several NNTPs were efﬁciently incorporated
by the strictly template-independent DNA pol TDT, para-
doxically, none of them was incorporated by the related
template-independent activity of DNA pol l. This observa-
tion demonstrates that the presence of a template strand is
essential for NNTPs incorporation by DNA pol l, even if,
in some cases, they further require the absence of a templat-
ing base (i.e. an abasic site), suggesting that additional inter-
actions with an intact sugar-phosphate backbone on the
template strand might be important.
Perhaps, the most surprising ﬁnding was the discovery of
the non-nucleoside compound IIb, which is incorporated by
DNA pol b in a strictly Mg
2+-dependent and template-
dependent manner. Strikingly, DNA pol b showed a clear
preference for incorporation of compound IIb opposite an
A. The so-called ‘A-rule’ predicts that when a DNA pol
encounters a lesion on the template strand, it often incor-
porates an A opposite the lesion (33). This rule, albeit not
absolute, is followed by many DNA pols, and the reason
lies in the favourable base-pairing properties of A, which
can then be accommodated in front of a variety of modi-
ﬁed bases. The results presented here suggest that, in the
case of compound IIb, pol b exploits the favourable
base-pairing properties of a templating A to accommodate
the incoming NNTP in the active site. This observation is
in agreement with the hypothesis that A-rich sequences
might be more prone to misincorporations by exonuclease-
deﬁcient DNA pols, as it has been suggested recently for
DNA pol l (34).
The biphenyl moiety of compound IIb has a length of 6.9
s and it is 2.7 s wide. As a comparison, the length of an
adenosine nucleoside is 7.4 s and its wideness is 2.5 s.
Also, the distance between the two phenyl rings in the biphe-
nyl moiety is 1.4 s, which is almost identical to the length of
the glycosidic bond connecting the ribose to the base in a
nucleoside, which is 1.5 s. No structure is available for com-
pound IIb; however, its biphenyl moiety lacks hydrogen
(H-) bonding groups and for this reason might be compared
to non-polar nucleoside analogs. Toluene, phenyl, styril,
pyrene and benzimidazole moieties have been exploited as
non-polar isosteres of natural bases (21). When coupled to
a5 0-triphosphate ribose, the resulting nucleoside analogs
are incorporated with variable efﬁciencies by DNA pols. In
particular, the non-polar shape analog of thymidine diﬂuoro-
toluene, could be efﬁciently processed by bacterial and viral
DNA pols, but not by DNA pol b, suggesting that this
enzyme is not able to recognize non-H-bonding analogs
(35). The results presented here with compound IIb seem to
indicate that H-bonding is not an absolute requirement for
nucleotide recognition and incorporation by DNA pol b.
However, the strong reduction in catalytic efﬁciency for IIb
incorporation opposite normal bases (95- to 1428-fold) might
be, at least in part, due to lack of H-bonding capability.
Indeed, recent pre-seady-state kinetic analysis have shown
that non-polar nucleotide analogs in the nascent base pair
caused a reduction of the incorporation efﬁciency by E.coli
DNA pol I (36).
The possibility of directing incorporation of non-
nucleoside molecules by DNA pols, not only opposite to
DNA lesions, as in the case of DNA pol l, but also in a
template-dependent manner, as for compound IIb and DNA
pol b, can be exploited for the development of a novel
class of molecular probes that can be used either for investi-
gating the DNA polymerase mechanisms and for potential
biotechnological applications. For example, non-nucleoside
chain-terminating triphosphates bearing markers groups
(such as ﬂuorescent groups) can be successfully applied
for DNA labelling during post-PCR target preparation for
microarray analysis.
Figure 6. NNTPs incorporation by calf thymus TDT. Reactions were carried out as detailed in Materials and Methods. TDT was assayed in the presence of a
19mer ssDNA oligonucleotide and increasing concentrations of compounds Ia (lanes 1–3), IIa and b (lanes 4–9), IIIb, d, e, f and c (lanes 10–27), and Ib (lanes
28–30). Lane M, control reaction without added nucleotides.
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